For instance, CD133 + ovarian cancer cells demonstrate heightened clonogenic and proliferative potential than CD133- cells, while elevated CD44 expression closely correlates with a poor prognosis of plasma ovarian cancer [12]. The gene discussed is PROM1; the disease is ovarian cancer.